Alkermes plc. (ALKS)

Latest Insider Confidence Score

2026Q1

48.7
Bearish

Company insider confidence (by quarter)

2016Q3 2026Q1

Largest shareholders

Insider Role (last 12 mo) Shares held Filed at
Pops Richard F CEO 1,290,390 Feb 7, 2025
Biberstein Kathryn L EVP/CAO/CCO/CRO Alks Inc 132,687 Feb 10, 2017
Bloom Floyd E Director 127,923 Jul 18, 2018
Hopkinson Craig C. EVP R&D, Chief Medical Officer 109,592 Dec 5, 2025
Nichols Christian Todd SVP, Chief Commercial Officer 86,208 Jun 10, 2025

Recent buy/sell transactions

Exec date Filing date Insider Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Mar 2, 2026 Mar 4, 2026 Reed Joshua CFO Neutral 52.5 - 0.00% ✗ -
Mar 2, 2026 Mar 4, 2026 POPS RICHARD F CEO Neutral 52.5 - 0.00% ✗ -
Mar 2, 2026 Mar 4, 2026 Parisi Samuel Joseph VP, Finance (Interim PAO) Sell 11.3 -6,890 -47.17% ✓ $201.8K
Mar 2, 2026 Mar 4, 2026 Nichols Christian Todd SVP, Chief Commercial Officer Sell 33.8 -6,000 -5.18% ✓ $180K
Mar 2, 2026 Mar 4, 2026 Jackson Blair Curtis COO Neutral 52.5 - 0.00% ✗ -
Mar 2, 2026 Mar 4, 2026 Hopkinson Craig C. EVP R&D, Chief Medical Officer Sell 28.8 -9,000 -9.15% ✓ $267.5K
Mar 2, 2026 Mar 4, 2026 Gaffin David Joseph EVP, CLO, Alkermes, Inc. Sell 46.3 -4,068 -1.70% ✓ $120.1K
Feb 26, 2026 Feb 27, 2026 Parisi Samuel Joseph VP, Finance (Interim PAO) Sell 26.3 -808 -5.24% ✗ $24.8K
Feb 26, 2026 Feb 27, 2026 Nichols Christian Todd SVP, Chief Commercial Officer Sell 22.5 -2,403 -2.03% ✗ $73.8K
Feb 26, 2026 Feb 27, 2026 Jackson Blair Curtis COO Sell 22.5 -3,695 -1.51% ✗ $113.5K
Feb 26, 2026 Feb 27, 2026 Hopkinson Craig C. EVP R&D, Chief Medical Officer Sell 22.5 -3,049 -3.16% ✗ $93.7K
Feb 26, 2026 Feb 27, 2026 Gaffin David Joseph EVP, CLO, Alkermes, Inc. Sell 22.5 -3,049 -1.26% ✗ $93.7K
Feb 23, 2026 Feb 25, 2026 Parisi Samuel Joseph VP, Finance (Interim PAO) Sell 26.3 -672 -5.04% ✗ $21.6K
Feb 23, 2026 Feb 25, 2026 Nichols Christian Todd SVP, Chief Commercial Officer Sell 22.5 -2,845 -2.46% ✗ $91.6K
Feb 23, 2026 Feb 25, 2026 Jackson Blair Curtis COO Sell 22.5 -3,880 -1.61% ✗ $124.9K
Feb 23, 2026 Feb 25, 2026 Hopkinson Craig C. EVP R&D, Chief Medical Officer Sell 22.5 -3,414 -3.67% ✗ $109.9K
Feb 23, 2026 Feb 25, 2026 Gaffin David Joseph EVP, CLO, Alkermes, Inc. Sell 22.5 -3,414 -1.43% ✗ $109.9K
Feb 18, 2026 Feb 20, 2026 Parisi Samuel Joseph VP, Finance (Interim PAO) Sell 22.5 -1,685 -7.73% ✗ $53.9K
Feb 18, 2026 Feb 20, 2026 Nichols Christian Todd SVP, Chief Commercial Officer Sell 22.5 -4,146 -1.90% ✗ $132.7K
Feb 18, 2026 Feb 20, 2026 Jackson Blair Curtis COO Sell 20.0 -7,926 -1.70% ✗ $253.7K
Feb 18, 2026 Feb 20, 2026 Hopkinson Craig C. EVP R&D, Chief Medical Officer Sell 22.5 -6,911 -3.99% ✗ $221.2K
Feb 18, 2026 Feb 20, 2026 Gaffin David Joseph EVP, CLO, Alkermes, Inc. Sell 22.5 -5,533 -1.19% ✗ $177.1K
Feb 5, 2026 Feb 6, 2026 POPS RICHARD F CEO Sell 95.0 +87,350 6.77% ✗ $2.1M
Feb 5, 2026 Feb 6, 2026 Nichols Christian Todd SVP, Chief Commercial Officer Sell 95.0 +14,738 17.10% ✗ $214.4K
Feb 5, 2026 Feb 6, 2026 Jackson Blair Curtis COO Sell 97.5 +20,184 10.02% ✗ $289.4K
Feb 5, 2026 Feb 6, 2026 Hopkinson Craig C. EVP R&D, Chief Medical Officer Sell 97.5 +17,898 31.00% ✗ $250.1K
Feb 5, 2026 Feb 6, 2026 Gaffin David Joseph EVP, CLO, Alkermes, Inc. Sell 92.5 +17,733 8.63% ✗ $255.6K
Feb 2, 2026 Feb 2, 2026 Hopkinson Craig C. EVP R&D, Chief Medical Officer Sell 25.0 -9,000 -13.49% ✓ $305.4K
Feb 2, 2026 Feb 2, 2026 Cooke Shane Director Sell 8.8 -61,200 -37.10% ✓ $2.1M
Jan 8, 2026 Jan 8, 2026 Hopkinson Craig C. EVP R&D, Chief Medical Officer Sell 33.8 -5,000 -7.49% ✓ $150K
Jan 2, 2026 Jan 2, 2026 Hopkinson Craig C. EVP R&D, Chief Medical Officer Sell 33.8 -4,000 -6.08% ✓ $112K
Dec 3, 2025 Dec 5, 2025 Hopkinson Craig C. EVP R&D, Chief Medical Officer Sell 32.5 -3,748 -5.39% ✓ $112.4K
Dec 1, 2025 Dec 1, 2025 Hopkinson Craig C. EVP R&D, Chief Medical Officer Sell 32.5 -4,000 -5.74% ✓ $117.2K
Nov 3, 2025 Nov 3, 2025 Hopkinson Craig C. EVP R&D, Chief Medical Officer Sell 22.5 -9,000 -11.43% ✓ $273.4K
Oct 15, 2025 Oct 15, 2025 Hopkinson Craig C. EVP R&D, Chief Medical Officer Sell 22.5 -9,000 -10.88% ✓ $283.8K
Oct 8, 2025 Oct 10, 2025 Reed Joshua CFO Neutral 52.5 - 0.00% ✗ -
Sep 23, 2025 Reed Joshua CFO Neutral 52.5 - 0.00% ✗ -
Aug 3, 2025 Aug 4, 2025 Gaffin David Joseph EVP, CLO, Alkermes, Inc. Sell 43.8 -895 -0.43% ✗ $23.8K
Jun 9, 2025 Jun 10, 2025 Nichols Christian Todd SVP, Chief Commercial Officer Sell 32.5 -6,667 -7.18% ✓ $210.1K
Jun 8, 2025 Jun 10, 2025 Wright Christopher I Director Sell 26.3 -793 -3.33% ✗ $25.1K
May 31, 2025 Jun 2, 2025 Wright Christopher I Director Sell 22.5 -1,924 -8.58% ✗ $58.9K
May 31, 2025 Jun 2, 2025 Wilson Frank Anders Director Sell 22.5 -1,924 -5.83% ✗ $58.9K
May 31, 2025 Jun 2, 2025 snyderman nancy lynn MD Director Sell 22.5 -1,924 -5.75% ✗ $58.9K
May 31, 2025 Jun 2, 2025 MCKEON BRIAN P Director Sell 22.5 -1,924 -4.20% ✗ $58.9K
May 31, 2025 Jun 2, 2025 Lurker Nancy Director Sell 22.5 -1,924 -15.23% ✗ $58.9K
May 31, 2025 Jun 2, 2025 LAURENCIN CATO T Director Sell 22.5 -1,924 -6.20% ✗ $58.9K
May 31, 2025 Jun 2, 2025 GAYNOR RICHARD Director Sell 22.5 -1,924 -5.83% ✗ $58.9K
May 31, 2025 Jun 2, 2025 Cooke Shane Director Sell 22.5 -4,175 -3.87% ✗ $127.8K
May 21, 2025 May 23, 2025 Wright Christopher I Director Neutral 52.5 - 0.00% ✗ -
May 21, 2025 May 23, 2025 Wilson Frank Anders Director Neutral 52.5 - 0.00% ✗ -
May 21, 2025 May 23, 2025 snyderman nancy lynn MD Director Neutral 52.5 - 0.00% ✗ -
May 21, 2025 May 23, 2025 MCKEON BRIAN P Director Neutral 52.5 - 0.00% ✗ -
May 21, 2025 May 23, 2025 Lurker Nancy Director Neutral 52.5 - 0.00% ✗ -
May 21, 2025 May 23, 2025 LAURENCIN CATO T Director Neutral 52.5 - 0.00% ✗ -
May 21, 2025 May 23, 2025 GAYNOR RICHARD Director Neutral 52.5 - 0.00% ✗ -
May 21, 2025 May 23, 2025 Cooke Shane Director Neutral 52.5 - 0.00% ✗ -
Apr 11, 2025 Apr 14, 2025 Lurker Nancy Director Sell 26.3 -1,459 -18.61% ✗ $39.4K
Feb 26, 2025 Feb 28, 2025 Parisi Samuel Joseph VP, Finance (Interim PAO) Sell 10.0 -2,746 -26.24% ✓ $94K
Feb 26, 2025 Feb 28, 2025 Nichols Christian Todd SVP, Chief Commercial Officer Sell 22.5 -2,402 -2.52% ✗ $83.6K
Feb 26, 2025 Feb 28, 2025 Jackson Blair Curtis COO Sell 22.5 -3,695 -1.80% ✗ $128.6K
Feb 26, 2025 Feb 28, 2025 Hopkinson Craig C. EVP R&D, Chief Medical Officer Sell 22.5 -3,049 -3.77% ✗ $106.1K
Feb 26, 2025 Feb 28, 2025 Gaffin David Joseph EVP, CLO, Alkermes, Inc. Sell 22.5 -3,049 -1.47% ✗ $106.1K
Feb 26, 2025 Feb 28, 2025 Brown Iain Michael CFO Sell 22.5 -2,494 -1.66% ✗ $86.8K
Feb 22, 2025 Feb 25, 2025 Gaffin David Joseph EVP, CLO, Alkermes, Inc. Sell 22.5 -6,714 -1.66% ✗ $237.1K
Feb 22, 2025 Feb 25, 2025 Jackson Blair Curtis COO Sell 20.0 -8,185 -2.06% ✗ $289.1K
Feb 22, 2025 Feb 25, 2025 Parisi Samuel Joseph VP, Finance (Interim PAO) Sell 20.0 -5,398 -15.68% ✓ $190.4K
Feb 22, 2025 Feb 25, 2025 Brown Iain Michael CFO Sell 22.5 -5,741 -1.96% ✗ $202.8K
Feb 22, 2025 Feb 25, 2025 Nichols Christian Todd SVP, Chief Commercial Officer Sell 22.5 -6,003 -3.30% ✗ $212K
Feb 22, 2025 Feb 25, 2025 Hopkinson Craig C. EVP R&D, Chief Medical Officer Sell 20.0 -8,866 -5.82% ✗ $313.1K
Feb 18, 2025 Feb 20, 2025 Parisi Samuel Joseph VP, Finance (Interim PAO) Sell 15.0 -2,033 -20.85% ✓ $72.7K
Feb 18, 2025 Feb 20, 2025 Nichols Christian Todd SVP, Chief Commercial Officer Sell 22.5 -1,869 -2.22% ✗ $67.1K
Feb 18, 2025 Feb 20, 2025 Gaffin David Joseph EVP, CLO, Alkermes, Inc. Sell 22.5 -2,822 -1.45% ✗ $101.3K
Feb 18, 2025 Feb 20, 2025 Brown Iain Michael CFO Sell 22.5 -1,869 -1.34% ✗ $67.1K
Feb 18, 2025 Feb 20, 2025 Jackson Blair Curtis COO Sell 22.5 -3,950 -2.07% ✗ $141.8K
Feb 18, 2025 Feb 20, 2025 Hopkinson Craig C. EVP R&D, Chief Medical Officer Sell 22.5 -3,950 -5.92% ✗ $141.8K
Feb 19, 2025 Feb 20, 2025 POPS RICHARD F CEO Neutral 52.5 - 0.00% ✗ -
Feb 12, 2025 Feb 14, 2025 Hopkinson Craig C. EVP R&D, Chief Medical Officer Sell 2.5 -349,340 -48.33% ✓ $11.8M
Feb 6, 2025 Feb 7, 2025 POPS RICHARD F CEO Sell 95.0 +110,715 9.39% ✗ $2.5M
Feb 6, 2025 Feb 7, 2025 Nichols Christian Todd SVP, Chief Commercial Officer Sell 95.0 +17,166 28.28% ✗ $232.3K
Feb 6, 2025 Feb 7, 2025 Jackson Blair Curtis COO Sell 97.5 +23,746 15.05% ✗ $334.2K
Feb 6, 2025 Feb 7, 2025 Hopkinson Craig C. EVP R&D, Chief Medical Officer Sell 97.5 +19,310 43.60% ✗ $473.5K
Feb 6, 2025 Feb 7, 2025 Gaffin David Joseph EVP, CLO, Alkermes, Inc. Sell 97.5 +22,598 13.62% ✗ $306.1K
Feb 6, 2025 Feb 7, 2025 Brown Iain Michael CFO Sell 95.0 +17,051 14.66% ✗ $235.9K
Jan 30, 2025 Jan 31, 2025 Hopkinson Craig C. EVP R&D, Chief Medical Officer Sell 5.0 -100,918 -69.50% ✓ $3.2M
Dec 9, 2024 Dec 9, 2024 Hopkinson Craig C. EVP R&D, Chief Medical Officer Sell 5.0 -61,151 -56.24% ✓ $2M
Dec 8, 2024 Dec 9, 2024 LAURENCIN CATO T Director Sell 32.5 -3,649 -7.35% ✓ $115.8K
Dec 5, 2024 Dec 5, 2024 Hopkinson Craig C. EVP R&D, Chief Medical Officer Sell 22.5 -9,221 -13.37% ✓ $290.5K
Dec 4, 2024 Dec 4, 2024 Hopkinson Craig C. EVP R&D, Chief Medical Officer Sell 17.5 -14,349 -17.23% ✓ $441.6K
Nov 27, 2024 Nov 27, 2024 Nichols Christian Todd SVP, Chief Commercial Officer Sell 28.8 -5,208 -7.90% ✓ $151.8K
Nov 11, 2024 Nov 12, 2024 Hopkinson Craig C. EVP R&D, Chief Medical Officer Sell 5.0 -58,996 -41.46% ✓ $1.8M
Nov 6, 2024 Nov 6, 2024 Hopkinson Craig C. EVP R&D, Chief Medical Officer Sell 26.3 -10,471 -9.54% ✓ $309.2K
Aug 3, 2024 Aug 5, 2024 Gaffin David Joseph EVP, CLO, Alkermes, Inc. Sell 36.3 -895 -0.54% ✗ $24.8K
Jun 29, 2024 Jul 1, 2024 Wright Christopher I Director Sell 26.3 -1,465 -9.22% ✗ $35.3K
Jun 29, 2024 Jul 1, 2024 Wilson Frank Anders Director Sell 26.3 -1,465 -5.54% ✗ $35.3K
Jun 29, 2024 Jul 1, 2024 snyderman nancy lynn MD Director Sell 26.3 -1,465 -5.45% ✗ $35.3K
Jun 29, 2024 Jul 1, 2024 MCKEON BRIAN P Director Sell 26.3 -1,465 -3.73% ✗ $35.3K
Jun 29, 2024 Jul 1, 2024 LAURENCIN CATO T Director Sell 26.3 -1,465 -6.89% ✗ $35.3K
Jun 29, 2024 Jul 1, 2024 GAYNOR RICHARD Director Sell 26.3 -1,465 -5.54% ✗ $35.3K
Jun 29, 2024 Jul 1, 2024 Daglio David Angelo Jr. Director Sell 26.3 -1,465 -1.34% ✗ $35.3K
Jun 29, 2024 Jul 1, 2024 Cooke Shane Director Sell 22.5 -3,175 -3.08% ✗ $76.5K